Vical Incorporated (NASDAQ: VICL) is focused on researching and developing biopharmaceutical products designed to prevent and treat serious or life-threatening diseases. Possible applications of the company’s DNA delivery technology include DNA vaccines for infectious diseases or cancer, cancer immunotherapeutics, and cardiovascular therapies. By strategically partnering with other pharmaceutical companies and biotechnology companies, the company hopes to expand its product pipeline. For further information, visit the Company’s web site at www.vical.com.
- 18 years ago
QualityStocks
Vical Incorporated (NASDAQ: VICL)
Tags Rodman & Renshaw
Related Post
-
Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments
In the United States alone, close to one million people are living with MS, with…
-
Why Verbal Skills Aren’t Enough: WRAP’s New Doctrine Aims to Give Officers a Lawful Next Step
California's SB 230 requires agencies to incorporate de-escalation and alternatives to force into their use-of-force…
-
Beeline Holdings Inc. (NASDAQ: BLNE) Partners with Loft 100 Studios to Examine the Mortgage Market and New Approaches to Homeownership
The partnership will focus on the production of a 45-minute “Bizumentary” examining current challenges and…